Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement for Aromatase Inhibitors-related Arthralgia Management (AIA): A prospective phase II trial (NCT04161833). (October 2020) - Desideri, I.; Lucidi, S.; Garlatti, P.; Lorenzetti, V.; Ciabatti, C.; Terziani, F.; Scotti, V.; Bonomo, P.; Francolini, G.; Meattini, I.; Livi, L.